Skip to content
Screener

Geron GERN Raw materials

Raw materials at other companies

Incyte logo
IncyteINCY
$49.78M+51.0%
Exelixis logo
ExelixisEXEL
$916K-60.9%
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$27.6M-17.6%
Gilead Sciences logo
Gilead SciencesGILD
$1.42B+11.3%
Eli Lilly logo
Eli LillyLLY
$4.13B+31.0%

Other financials

Income statement

See full
Revenue$57.5M+17.2%
Operating income-$12.5M-0.3%
Net income-$16.7M-1.9%
EPS (diluted)-$0.020.0%

Balance sheet

See full
Cash & equivalents$64.5M-18.9%
Total debt$134.1M-0.3%
Total equity$218.6M-15.8%
Total assets$519.0M-6.5%

Cash flow

See full
Operating cash flow-$15.8M+42.3%
CapEx$206.0K+2.0%
Free cash flow-$43.8M-6.8%

Valuation

See full
Market cap$949.45M+9.4%
Enterprise value$1.02B+10.4%
P/S4.6×-170×

Profitability

See full
Operating margin-705.5%-351pp
Net margin-682.5%-339pp
FCF margin-734.4%-365pp

Returns & leverage

See full
Return on equity-28.3%-2.3pp
Debt / equity0.6×+0.1×
Current ratio6.9×-1.0×

Where this comes from

Reported directly by Geron in its filing.

Tagged under the XBRL concept us-gaap:InventoryRawMaterialsNetOfReserves.

The source filing: Geron’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:41 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000886744-26-000037
(in thousands)June 30, 2026December 31, 2025
Raw materials$7,955$8,927
Work-in-process98,18891,969
Finished goods17,46115,740
Total inventory$123,604$116,636

ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)

FAQ

What is Geron's raw materials?
Geron (GERN) reported raw materials of $7.96M in Q2 2026.
How has Geron's raw materials changed year-over-year?
Geron's raw materials increased by 4.9% year-over-year, from $7.58M to $7.96M.
What does raw materials mean?
Unprocessed materials and components purchased for use in manufacturing, valued at cost.

Ask your AI about Geron's raw materials.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude